4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0000899243-18-024470
CIK 0001404281other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:00 PM ET
Size
7.8 KB
Accession
0000899243-18-024470
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Purchase
Common Stock
2018-09-11$4.56/sh+17,048$77,671→ 61,567 total - Purchase
Common Stock
2018-09-12$5.02/sh+16,632$83,476→ 78,199 total
Holdings
- 805(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $4.47 to $4.70. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.97 to $5.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 8:00 PM ET
- Size
- 7.8 KB